Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 22,576–22,600 of 27,380 studies, newest first · page 904 of 1096.

June 2007 12

  1. 2007-06-01

    Depression rating scales in Parkinson's disease: critique and recommendations

    ✓ Peer-reviewed Risk factors Movement disorders : official journal of the Movement Disorder Society

    Key finding: For measurement of severity of depressive symptoms, the Ham-D, MADRS, BDI, and SDS scales are recommended. +4 more findings

  2. 2007-06-01

    Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees

    ✓ Peer-reviewed Brain scans and imaging The Journal of neuroscience : the official journal of the Society for Neuroscience

    Key finding: The amyloid cascade hypothesis suggests that the aggregation and deposition of amyloid-beta protein is an initiating event in Alzheimer's disease (AD). +4 more findings

  3. 2007-06-01

    Forget me not: palliative care for people with dementia

    ✓ Peer-reviewed End-of-life care Postgraduate medical journal

    Key finding: Dementia is a progressive life limiting condition with increasing prevalence and complex needs. +2 more findings

  4. 2007-06-01

    Systematic review of driving risk and the efficacy of compensatory strategies in persons with dementia

    ✓ Peer-reviewed Clinical safety Journal of the American Geriatrics Society

    Key finding: Drivers with dementia are poorer drivers than cognitively normal drivers, but studies have not consistently demonstrated higher crash rates. +2 more findings

  5. 2007-06-01
  6. 2007-06-01

    Effects of sociodemographic and health variables on Mini-Mental State Exam scores in older Australians

    ✓ Peer-reviewed Cognitive tests and assessment The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry

    Key finding: The regression models showed that older age, education levels, language spoken at home and in country of birth, socioeconomic status (SES), occupation, sex, and presence of a mood disorder made significant and unique contributions to performance on the MMSE. +3 more findings

  7. 2007-06-01

    Irreversible motor impairment in young addicts--ephedrone, manganism or both?

    ✓ Peer-reviewed Cognitive tests and assessment Acta neurologica Scandinavica

    Key finding: Parkinsonian syndrome related to intravenous use of a "designer" psychostimulant, derived from pseudoephedrine using potassium permanganate as the oxidant, has been observed in drug addicts in Estonia. +3 more findings

  8. 2007-06-01

    Levels of beta-secretase (BACE1) in cerebrospinal fluid as a predictor of risk in mild cognitive impairment

    ✓ Peer-reviewed Risk genes beyond APOE Archives of general psychiatry

    Key finding: Elevated beta-secretase (beta-site amyloid precursor protein-cleaving enzyme 1 [BACE1]) activity has been found in the brains of patients with sporadic Alzheimer disease (AD) compared with controls. +3 more findings

  9. 2007-06-01

    The rate of conversion of mild cognitive impairment to dementia: predictive role of depression

    ✓ Peer-reviewed Mild cognitive impairment International journal of geriatric psychiatry

    Key finding: We conclude that conversion rate from MCI to DSM-IIIR dementia was 21.9% over a period of 3 years. +3 more findings

  10. 2007-06-01

    Neuropsychological measures in normal individuals that predict subsequent cognitive decline

    ✓ Peer-reviewed Mild cognitive impairment Archives of neurology

    Key finding: Tests of both episodic memory and executive function are predictors of time to progression from mild impairment to a clinical diagnosis of Alzheimer disease.

  11. 2007-06-01

    Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study

    ✓ Peer-reviewed Mild cognitive impairment The Lancet. Neurology

    Key finding: Of 1018 study patients enrolled, 508 were randomly assigned to rivastigmine and 510 to placebo; 17.3% of patients on rivastigmine and 21.4% on placebo progressed to AD (hazard ratio 0.85 [95% CI 0.64-1.12]; p=0.225). +3 more findings

  12. 2007-06-01

    Antipsychotic drug use and mortality in older adults with dementia

    ✓ Peer-reviewed How common it is Annals of internal medicine

    Key finding: Atypical antipsychotic use is associated with an increased risk for death compared with nonuse among older adults with dementia. +4 more findings

May 2007 13

  1. 2007-05-29

    A genomewide screen for late-onset Alzheimer disease in a genetically isolated Dutch population

    ✓ Peer-reviewed Risk genes beyond APOE American journal of human genetics

    Key finding: We conducted a genome screen of 103 patients with late-onset AD who were ascertained as part of the Genetic Research in Isolated Populations (GRIP) program that is conducted in a recently isolated population from the southwestern area of The Netherlands. +3 more findings

  2. 2007-05-29

    Evolution of cognitive dysfunction in an incident Parkinson's disease cohort

    ✓ Peer-reviewed Getting a diagnosis Brain : a journal of neurology

    Key finding: We have previously performed detailed clinical and neuropsychological assessments in a community-based cohort of patients with newly diagnosed parkinsonism, and through analysis of a subcohort with idiopathic Parkinson's disease (PD), we have demonstrated that cognitive dysfunction occurs even at the time of PD diagnosis and is heterogeneous.

  3. 2007-05-28

    3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease

    ✓ Peer-reviewed Mild cognitive impairment Brain : a journal of neurology

    Key finding: Voxel-based morphometry (VBM) was used to assess patterns of grey matter atrophy in the aMCI subjects at each time-point compared to the control group. +3 more findings

  4. 2007-05-25
  5. 2007-05-24

    Occupational risk factors in Alzheimer's disease: a review assessing the quality of published epidemiological studies

    ✓ Peer-reviewed Risk factors Occupational and environmental medicine

    Key finding: For pesticides, studies of greater quality and prospective design found increased and statistically significant associations.

  6. 2007-05-23

    Hospice care for patients with dementia

    ✓ Peer-reviewed End-of-life care Journal of pain and symptom management

    Key finding: Evaluation of care in all FEHC domains did not significantly differ between groups. +2 more findings

  7. 2007-05-23

    Diffusion tensor imaging in preclinical and presymptomatic carriers of familial Alzheimer's disease mutations

    ✓ Peer-reviewed Brain tissue and pathology Brain : a journal of neurology

    Key finding: There is evidence from animal, pathological and imaging studies that disruption of white matter occurs in the course of Alzheimer's disease and may be an early event. +3 more findings

  8. 2007-05-18

    Dual Eligibles Faced Serious Health Problems in Shift to Part D

    ✓ Peer-reviewed Health systems and care delivery Psychiatric News

    Key finding: The results were announced earlier this month at a press conference in Washington D.C., and were published in the May American Journal of Psychiatry. +4 more findings

  9. 2007-05-18

    Cognitive and neuroimaging predictors of instrumental activities of daily living

    ✓ Peer-reviewed Caregiving Journal of the International Neuropsychological Society : JINS

    Key finding: Participants were 124 elderly persons with cognitive function between normal and moderate dementia both with and without significant small vessel cerebrovascular disease. +3 more findings

  10. 2007-05-08

    Proteomics Analysis of the Alzheimer's Disease Hippocampal Proteome

    ✓ Peer-reviewed Genetics Journal of Alzheimer s Disease

    Key finding: Protein levels were found to be significantly decreased for peptidyl prolyl cis/trans-isomerase (Pin 1) (0.6-fold compared to control, p<0.03), dihydropyrimidinase-like protein 2 (DRP-2) (0.74-fold compared to control, p<0.02), phosphoglycerate mutase 1 (PGM1) (0.7-fold compared to control, p<0.01), beta-tubulin (0.34-fold compared to control, p<0.01), and aldolase A (0.87-fold compared to control, p<0.0002), whereas the protein levels were found to be significantly increased for enolase (1.35-fold compared to control, p<0.05), ubiquitin carboxyl terminal hydrolase L-1 (UCH L1) (1.31-fold compared to control, p<0.02), triosephosphate isomerase (TPI) (1.38-fold compared to control, p<0.05), carbonic anhydrase II (CAH-II) (1.24-fold compared to control, p=0.05), heat shock protein 70 (1.14-fold compared to control, p<0.03), fructose bisphosphate aldolase (1.38-fold compared to control, p<0.05), ferritin heavy chain (1.23-fold compared to control, p=0.05), 2',3'-cyclic nucleotide 3' phosphodiestrase (CNPase) (1.12-fold compared to control, p<0.02), peroxiredoxin II (1.39-fold compared to control, p<0.05), and adenylate kinase I (1.19-fold compared to control, p<0.03). +2 more findings

  11. 2007-05-07

    Epitope mapping of mAbs AT8 and Tau5 directed against hyperphosphorylated regions of the human tau protein

    ✓ Peer-reviewed Drug development Biochemical and biophysical research communications

    Key finding: NFTs mostly consist of hyperphosphorylated versions of the microtubule attached tau protein (PHF-tau) with more than 30 serine and threonine phosphorylation sites identified so far. +4 more findings

  12. 2007-05-06

    Geniposide, a novel agonist for GLP-1 receptor, prevents PC12 cells from oxidative damage via MAP kinase pathway

    ✓ Peer-reviewed Drug development Neurochemistry international

    Key finding: The results demonstrated that geniposide increased the expression of anti-apoptotic proteins, including Bcl-2 and heme oxygenase-1 (HO-1), to antagonize the oxidative damage in PC12 cells induced by hydrogen peroxide.

  13. 2007-05-03

    Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model

    ✓ Peer-reviewed Disease mechanisms Science

    Many potential treatments for Alzheimer's disease target amyloid-beta peptides (Abeta), which are widely presumed to cause the disease.

Browse the library by subject, with the full score breakdown →